{"data":{"symbol":"BCLI","companyName":"Brainstorm Cell Therapeutics Inc. Common Stock","stockType":"Common Stock","exchange":"NASDAQ-CM","isNasdaqListed":true,"isNasdaq100":false,"isHeld":false,"primaryData":{"lastSalePrice":"$2.92","netChange":"+0.23","percentageChange":"+8.55%","deltaIndicator":"up","lastTradeTimestamp":"Feb 10, 2023","isRealTime":false,"bidPrice":"N/A","askPrice":"N/A","volume":"614,910"},"secondaryData":null,"marketStatus":"Closed","assetClass":"STOCKS","keyStats":null,"notifications":[{"headline":"HIGH TECHNICAL ATTRIBUTE","eventTypes":[{"message":"BCLI has a High Technical Rating by Nasdaq Dorsey Wright. Discover why technical analysis matters","eventName":"High Technical Attribute","url":{"label":"Discover why technical analysis matters","value":"https://www.nasdaq.com/solutions/nasdaq-dorsey-wright/technical-analysis"},"id":"tech_attribute"}]}]},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}